Cardio Diagnostics Holdings, Inc.
NASDAQ: CDIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Meeshanthini V. Dogan
- Employees
- 13
- Headquarters
- Chicago, United States
- IPO year
- 2022
- Market cap
- $4.2M
- Website
- https://cardiodiagnosticsinc.com
Loading CDIO…
Loading profile data…Frequently asked questions about CDIO
What does Cardio Diagnostics Holdings, Inc. (CDIO) do?
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This compan...
Where does CDIO trade?
Cardio Diagnostics Holdings, Inc. (CDIO) trades on the NASDAQ Capital Market.
What sector is CDIO in?
Cardio Diagnostics Holdings, Inc. (CDIO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cardio Diagnostics Holdings, Inc.?
Meeshanthini V. Dogan is the chief executive officer of Cardio Diagnostics Holdings, Inc. (CDIO).
Where is Cardio Diagnostics Holdings, Inc. headquartered?
Cardio Diagnostics Holdings, Inc. is headquartered in United States.
Does CDIO pay a dividend?
Cardio Diagnostics Holdings, Inc. (CDIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CDIO go public?
Cardio Diagnostics Holdings, Inc. (CDIO) completed its initial public offering in 2022.